pocketful logo light
pocketful logo light
Gujarat Themis Biosyn Ltd logo

Gujarat Themis Biosyn Ltd

NSE: GUJTHEM BSE: 506879

355.60

(0.18%)

Mon, 25 May 2026, 06:41 am

Gujarat Themis Biosyn Share Price Live Chart

1 Day

(0.18%)

No Result Found

Summary

  • Market Cap

    4019.18

  • Net Profit

    48.77

  • P/B

    12.35

  • Sector P/E

    45.26

  • P/E

    62.83

  • EV/EBITDA

    43.29

  • Debt/Equity (Industry)

    0.17

  • Interest Cover (Industry)

    18.19

  • ROCE (Industry)

    20.67

  • RONW (Industry)

    17.71

  • ROE

    21.69

  • ROCE

    27.21

  • Debt/Equity

    0.07

  • EPS (TTM)

    4.39

  • Dividend Yield

    0.18

  • Book Value

    24.27

  • Interest Cover

    183.06

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters70.8670.8670.8670.8670.86
FII1.801.962.952.511.91
DII1.181.171.171.171.17
Public26.1626.0025.0125.4526.05
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

64.19

MACD

12.37

50 DMA

320.42

200 DMA

369.96

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic627.17477.18420.38327.19270.39177.2027.21
Fibonacci477.18419.88384.49327.19269.89234.50177.20
Camarilla404.83391.08377.33327.19349.83336.08322.33

Pivots Level: Classic

R3

+299.98

627.17

R2

+149.99

477.18

R1

+93.19

420.38

327.19
327.19
Pivot Point
LTP: 395.50

S1

-56.80

270.39

S2

-149.99

177.20

S3

-299.98

27.21

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    369.73

  • 20-EMA

    362.05

  • 30-EMA

    352.84

  • 50-EMA

    342.45

  • 100-EMA

    342.27

  • 200-EMA

    341.43

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
25 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
05 Feb 2026board-meetingsQuarterly Results
20 Aug 2025agm
05 Aug 2025dividendFinal Dividend - Rs. - 0.6705 Sept 2025
04 Aug 2025dividendDividend - Re 0.67 Per Share05 Sept 2025
20 May 2025dividend₹0.67 Dividend /Share05 Sept 2025
31 Jul 2024bonus1:2 Bonus Issue of Equity Shares09 Aug 2024
09 Jul 2024bonusBonus issue 1:209 Aug 2024
14 May 2024agm
14 May 2024dividend₹0.25 Dividend /Share16 Jul 2024

Read More

Peer Comparison

Gujarat Themis Biosyn Ltd logo

Gujarat Themis Biosyn Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Gujarat Themis Biosyn Ltd About

Gujarat Themis Biosyn engaged in the activities pertaining to manufacturing of Bulk Drugs.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1981

Headquarters

CEO

Dinesh S Patel

Employees

Contact

Website icon

Website

http://www.gtbl.in

Email icon

Email

gtblmumbai@gtbl.in; admin@gtbl.co.in

Phone icon

Phone

91-260-2430027

Location icon

Location

69/C GIDC Industrial Estate, Valsad Dist, VAPI, Gujarat, 396195

Read More

Gujarat Themis Biosyn Ltd Company History

YearHistory
No Result Found

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy590941367.2224 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell590941367.4824 Apr 2026
PHARMACEUTICAL BUSINESS GROUP I LTDbulkSell3000000215.3527 Dec 2023
MC JAIN INFOSERVICES PRIVATE LIMITEDbulkBuy49000021527 Dec 2023
NEELKAMAL MOTILAL PAREKHbulkSell7500050.1921 Apr 2017
MANJU PAREKHbulkBuy7500050.1921 Apr 2017
PRABHAT PRABHATbulkBuy2231639.3116 Mar 2015
PRABHAT PRABHATbulkSell9377338.2616 Mar 2015
PRABHAT PRABHATbulkBuy7817836.6113 Mar 2015
PRABHAT PRABHATbulkSell672137.913 Mar 2015

Read More

Gujarat Themis Biosyn Ltd News

GTBL Acquires MicroBiopharm Japan for JPY 21.5 Billion

Gujarat Themis Biosyn enters definitive agreement to acquire 100% of MicroBiopharm Japan Co., Ltd. for JPY 21.5 Billion (~INR 1,300 Crores), with deal closure expected in Q2 FY2027.

22 May 2026

companies

Gujarat Themis sets up Japan unit

Gujarat Themis Biosyn incorporated a wholly owned subsidiary, Themis Biosyn Japan Limited, on May 19, 2026.

19 May 2026

companies

Gujarat Themis Biosyn Board Meet on May 25 for FY26 Results

Gujarat Themis Biosyn has scheduled a Board of Directors meeting on May 25, 2026, to approve audited financial results for Q4 and FY26, and consider dividend recommendation.

19 May 2026

companies

Gujarat Themis Biosyn Postal Ballot Notice

Gujarat Themis Biosyn Limited has announced a postal ballot for special resolutions regarding borrowing limits and loan provisions. E-voting commences on 6th May 2026.

06 May 2026

companies

Gujarat Themis Biosyn Releases Investor Presentation

Gujarat Themis Biosyn Limited submits investor presentation to stock exchanges regarding €158 million acquisition of Sanofi's global anti-TB and anti-infective portfolio under Regulation 30.

25 Apr 2026

companies

Read More